Studies of the ovarian tumour suppressor protein OPCML with a view to determining its structure and understanding its role in modulating RTK signalling
The opioid-binding cell adhesion molecule (OPCML) is a glycosylphosphatidylinositol (GPI) anchored protein that was found to be epigenetically inactivated in 83% of ovarian cancers and demonstrated to act as a tumour suppressor gene (TSG), inhibiting tumour cell growth in vitro and severely attenuat...
Main Author: | Zanini, Elisa |
---|---|
Other Authors: | Chayen, Naomi ; Mckie, Arthur |
Published: |
Imperial College London
2013
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.693956 |
Similar Items
-
Clinical biology of OPCML and its potential therapeutic applications in ovarian and breast cancers
by: Louis, Louay
Published: (2014) -
Acetylation control of the retinoblastoma tumour suppressor protein
by: Markham, Douglas James
Published: (2006) -
Role for tumour suppressor Merlin in gene expression
by: Rohrig, A. E.
Published: (2013) -
The roles and regulation of the Drosophila Lgl tumour suppressor in cell division
by: Bell, G. P.
Published: (2014) -
Human ribosome biogenesis and the regulation of the tumour suppressor p53
by: Pelava, Andria
Published: (2017)